Feature

The end of happy hour? No safe level of alcohol for the brain


 

Experts weigh in

Several experts weighed in on the study in a statement from the nonprofit UK Science Media Center.

Paul Matthews, MD, head of the department of brain sciences, Imperial College London, noted that this “carefully performed preliminary report extends our earlier UK Dementia Research Institute study of a smaller group from same UK Biobank population also showing that even moderate drinking is associated with greater atrophy of the brain, as well as injury to the heart and liver.”

Dr. Matthews said the investigators’ conclusion that there is no safe threshold below which alcohol consumption has no toxic effects “echoes our own. We join with them in suggesting that current public health guidelines concerning alcohol consumption may need to be revisited.”

Rebecca Dewey, PhD, research fellow in neuroimaging, University of Nottingham (England), cautioned that “the degree to which very small changes in brain volume are harmful” is unknown.

“While there was no threshold under which alcohol consumption did not cause changes in the brain, there may a degree of brain volume difference that is irrelevant to brain health. We don’t know what these people’s brains looked like before they drank alcohol, so the brain may have learned to cope/compensate,” Dewey said.

Sadie Boniface, PhD, head of research at the Institute of Alcohol Studies and visiting researcher at King’s College London, said, “While we can’t yet say for sure whether there is ‘no safe level’ of alcohol regarding brain health at the moment, it has been known for decades that heavy drinking is bad for brain health.

“We also shouldn’t forget alcohol affects all parts of the body and there are multiple health risks. For example, it is already known there is ‘no safe level’ of alcohol consumption for the seven types of cancer caused by alcohol, as identified by the UK chief medical officers,” Dr. Boniface said.

The study was supported in part by the Wellcome Trust, Li Ka Shing Center for Health Information and Discovery, the National Institutes of Health, and the UK Medical Research Council. Dr. Topiwala, Dr. Boniface, Dr. Dewey, and Dr. Matthews have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA OKs higher-dose naloxone nasal spray for opioid overdose
MDedge Psychiatry
National poll shows ‘concerning’ impact of COVID on Americans’ mental health
MDedge Psychiatry
Adulterants in street drugs could increase susceptibility to COVID
MDedge Psychiatry
Blood biomarker a ‘promising’ predictor of psychosis relapse
MDedge Psychiatry
Opioid addiction meds may curb growing problem of kratom dependence
MDedge Psychiatry
Depot buprenorphine a shot in the arm for opioid addiction?
MDedge Psychiatry
Acts of kindness, empathy bolster mental health
MDedge Psychiatry
HHS to inject billions into mental health, substance use disorders
MDedge Psychiatry
Prevalence of psychiatric disorders higher in adult cerebral palsy patients
MDedge Psychiatry
Unhealthy drinking may worsen after weight loss surgery
MDedge Psychiatry